Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
K. Malmberg(Karolinska University Hospital), Kåre I. Birkeland(Oslo University Hospital), Per Hildebrandt(Frederiksberg Hospital), Miles Fisher, Anders Waldenström(Cornell University), Lars Rydén(Karolinska Institutet), Suad Efendić(Karolinska University Hospital), Johan Herlitz(Sahlgrenska University Hospital), Christian Torp‐Pedersen(University of Copenhagen), K. M. MacLeod(Royal Devon and Exeter Hospital), Markku Laakso(Cleveland Clinic), Aart H. Bootsma(Erasmus MC), Kenneth Dickstein(Stavanger University Hospital), Hans Wedel(Sahlgrenska University Hospital), Anders Hamsten
Cited by 1,064
Related Papers
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
|The Lancet|1998|5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
|New England Journal of Medicine|2004|4.5k